ClassID:

96736

C07K7/06 - page 13 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids

Recent Application in this class:
#3601
20140199332
2014-07-17

Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same

#3602
20140199325
2014-07-17

Polypeptides and use thereof

#3603
20140194365
2014-07-10

Use of endostatin peptides for the treatment of fibrosis

#3604
20140194347
2014-07-10

Influenza inhibiting compositions and methods

#3605
20140193465
2014-07-10

α4β7 peptide dimer antagonists

#3606
20140193443
2014-07-10

Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same

#3607
20140193442
2014-07-10

Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same

#3608
20140187748
2014-07-03

Mirac proteins

#3609
20140187746
2014-07-03

Precipitable peptides

#3610
20140187472
2014-07-03

Template-fixed peptidomimetics with antimicrobial activity

#3611
20140187471
2014-07-03

Template-fixed peptidomimetics with antimicrobial activity

#3612
20140187444
2014-07-03

Methods and compositions for detecting and modulating O-glycosylation

#3613
20140186403
2014-07-03

PEPTIDE FOR VACCINE

#3614
20140186379
2014-07-03

Macromolecule transduction domains and methods for identification and uses thereof

#3615
20140186313
2014-07-03

Beta sheet tapes ribbons in tissue engineering

#3616
20140179901
2014-06-26

Peptide Conjugates and Fluorescence Detection Methods for Intracellular Caspase Assay

#3617
20140179900
2014-06-26

TREATMENT OF ATHEROSCLEROSIS WITH CHOLESTEROL ESTER TRANSPORT PROTEIN MIMOTOPES

#3618
20140179708
2014-06-26

Substituted piperazin-2,5-diones as multifunctional bioactive compounds

#3619
20140179616
2014-06-26

Peptides that stimulate subcutaneous adipogenesis

#3620
20140179592
2014-06-26

Compounds containing a vascular disrupting agent

#3621
20140178990
2014-06-26

Cell proliferation-promoting peptide and use thereof

#3622
20140178394
2014-06-26

Antigen peptide and uses thereof

#3623
20140178381
2014-06-26

Retrograde transport peptide and use of same for delivery to central nervous system

#3624
20140178375
2014-06-26

Antibody-like proteins for therapeutic and diagnostic use

#3625
20140178352
2014-06-26

Peptide inhibitors of protein kinase C

#3626
20140178309
2014-06-26

Protection of cells from -RNA-induced degeneration and inhibitors for protecting cells

#3627
20140171622
2014-06-19

Fusion proteins forming trimers

#3628
20140171619
2014-06-19

PEPTIDE-CROSSLINKED BIOACTIVE POLYMERIC MATERIALS

#3629
20140171377
2014-06-19

NOVEL PEPTIDES THAT ENHANCE TIGHT JUNCTION PERMEABILITY

#3630
20140171373
2014-06-19

Compositions and methods related to tauopathy

#3631
20140163203
2014-06-12

Process for preparing eptifibatide

#3632
20140162331
2014-06-12

Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof

#3633
20140161786
2014-06-12

Therapeutic compositions and related methods

#3634
20140161777
2014-06-12

METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES

#3635
20140161725
2014-06-12

Molecular imaging of cancer cells in vivo

#3636
20140155576
2014-06-05

F11 receptor (F11R) antagonists as therapeutic agents

#3637
20140155323
2014-06-05

Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides

#3638
20140155319
2014-06-05

Antimicrobial compositions and methods of use thereof

#3639
20140155318
2014-06-05

Peptides and compositions for prevention of cell adhesion and methods of using same

#3640
20140155317
2014-06-05

Selectively targeted antimicrobial peptides and the use thereof

#3641
20140155314
2014-06-05

Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion

#3642
20140154272
2014-06-05

Compound and method for modulating opioid receptor activity

#3643
20140154249
2014-06-05

Chemokine binding polypeptides for treating autoimmunity and inflammation

#3644
20140148394
2014-05-29

Compositions and methods for modulating gamma-c-cytokine activity

#3645
20140148393
2014-05-29

Amidated dopamine neuron stimulating peptides for CNS dopaminergic upregulation

#3646
20140148378
2014-05-29

ANTIBACTERIAL PEPTIDES

#3647
20140142044
2014-05-22

Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

#3648
20140142029
2014-05-22

Macrocyclic broad spectrum antibiotics

#3649
20140141064
2014-05-22

HLA-A2 tumor associated antigen peptides and compositions

#3650
20140141028
2014-05-22

Melk epitope peptides and vaccines containing the same

#3651
20140141027
2014-05-22

Peptide vaccines for cancers expressing tumor-associated antigens

#3652
20140141004
2014-05-22

Immunogenic peptides and methods of use for treating and preventing cancer

#3653
20140140929
2014-05-22

CHEMICALLY MODIFIED CELL-PENETRATING PEPTIDES FOR IMPROVED DELIVERY OF GENE MODULATING COMPOUNDS

#3654
20140140926
2014-05-22

Peptides and methods using same

#3655
20140135276
2014-05-15

Lipopeptide inhibitors of RAS oncoproteins

#3656
20140135272
2014-05-15

NOVEL ZINC FINGER-LIKE PEPTIDE COMPOSITIONS AS POTENT AGENTS IN CANCER PREVENTION AND TREATMENT

#3657
20140134657
2014-05-15

Screening methods for identifying proteases inhibitors

#3658
20140134295
2014-05-15

Method for transforming a bacterium belonging to the genus by natural competence

#3659
20140134198
2014-05-15

EphA2 T-cell epitope agonists and uses therefore

#3660
20140130209
2014-05-08

Modified plant defensins useful as anti-pathogenic agents

#3661
20140128328
2014-05-08

PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME

#3662
20140128321
2014-05-08

METHOD AND USE OF PEPTIDE ANTAGONISTS OF ZONULIN TO PREVENT OR DELAY THE ONSET OF DIABETES

#3663
20140128313
2014-05-08

Antimicrobial peptides and uses therefore

#3664
20140127269
2014-05-08

Anti-Inflammatory Peptide Derived From Thrombospondin-1 and Uses Thereof

#3665
20140121170
2014-05-01

Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles

#3666
20140121168
2014-05-01

ANTAGONISTS OF TRPV1 RECEPTOR

#3667
20140121165
2014-05-01

Induction of the mitochondrial permeability transition

#3668
20140120141
2014-05-01

Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions

#3669
20140114050
2014-04-24

Use of peptides for promoting wound healing

#3670
20140113871
2014-04-24

Modification of peptides via SAr reactions of thiols with fluorinated aromatics

#3671
20140113858
2014-04-24

Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof

#3672
20140112976
2014-04-24

Cyclic peptides with an anti-neoplasic and anti-angiogenic activity

#3673
20140112947
2014-04-24

Polypeptide inhibitors of HSP27 kinase and uses therefor

#3674
20140112873
2014-04-24

Melanocortin 1 receptor ligands and methods of use

#3675
20140107318
2014-04-17

PROCESSES AND INTERMEDIATES

#3676
20140107317
2014-04-17

Selective targeting agents for mitochondria

#3677
20140107039
2014-04-17

Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof

#3678
20140107031
2014-04-17

Template-fixed peptidomimetics

#3679
20140106341
2014-04-17

Stabilized bioactive peptides and methods of identification, synthesis, and use

#3680
20140105921
2014-04-17

Prodrugs of Peptide Epoxy Ketone Protease Inhibitors

#3681
20140100355
2014-04-10

Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates

#3682
20140100354
2014-04-10

PEPTOID COMPOSITIONS AND METHODS OF USING THE SAME

#3683
20140100353
2014-04-10

Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates

#3684
20140100170
2014-04-10

Plant-derived elastin binding protein ligands and methods of using the same

#3685
20140100168
2014-04-10

Prodrugs of peptide epoxy ketone protease inhibitors

#3686
20140100155
2014-04-10

Combination therapy and kit for the prevention and treatment of cystic fibrosis

#3687
20140100154
2014-04-10

Prodrugs of peptide epoxy ketone protease inhibitors

#3688
20140099655
2014-04-10

Methods for assaying enzyme activities

#3689
20140094586
2014-04-03

HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide

#3690
20140094415
2014-04-03

High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain

#3691
20140094414
2014-04-03

COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE INCLUDING BIOACTIVE PEPTIDE AS EFFECTIVE COMPONENT

#3692
20140094409
2014-04-03

ANTAGONIST FOR (PRO)RENIN RECEPTOR FOR THE TREATMENT OF HYPERTENSION AND DIABETES

#3693
20140094400
2014-04-03

Angiotensin Type 2 (AT2) receptor agonists and uses thereof

#3694
20140093892
2014-04-03

Marker comprising anti-CK8/18 complex autoantibody and its use for diagnosing cancer

#3695
20140093521
2014-04-03

Therapeutic DLL4 binding proteins

#3696
20140093473
2014-04-03

Amphiphilic linear peptidepeptoid and hydrogel comprising the same

#3697
20140088290
2014-03-27

Melanoma antigen peptide and uses thereof

#3698
20140088023
2014-03-27

sGCalphal inhibiting compositions

#3699
20140088017
2014-03-27

USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME

#3700
20140087994
2014-03-27

Template-fixed peptidomimetics with antimicrobial activity

#3701
20140086981
2014-03-27

PGC-1α-modulating peptides

#3702
20140086945
2014-03-27

Albumin-amyloid peptide conjugates and uses thereof

#3703
20140086832
2014-03-27

Delivery system for cytotoxic drugs by bispecific antibody pretargeting

#3704
20140080996
2014-03-20

Skin or hair binding peptides

#3705
20140080995
2014-03-20

Processes for the manufacture of macrocyclic depsipeptides and new intermediates

#3706
20140080762
2014-03-20

HYD1 PEPTIDES FOR RELAPSED CANCER

#3707
20140079753
2014-03-20

BMP BINDING PEPTIDES

#3708
20140079650
2014-03-20

Stabilized calcium phosphate complexes

#3709
20140073556
2014-03-13

Antagonists of the interleukin-1 receptor

#3710
20140072574
2014-03-13

Method of treating eosinophilia by administering an immunomodulating peptide

#3711
20140072566
2014-03-13

Antibody specifically recognizing an epitope for switching to Th2 cell and a method for converting T cell to type 2 helper T cell using the same

#3712
20140072565
2014-03-13

Monoclonal antibody specifically recognizing an epitope for switching to Th17 cell

#3713
20140066594
2014-03-06

BINDING LIGAND LINKED DRUG DELIVERY CONJUGATES OF TUBULYSINS

#3714
20140066387
2014-03-06

Functionalized biomaterials for tissue regeneration

#3715
20140066381
2014-03-06

Peptides that are modulators of the protein TRF2 and compositions containing same

#3716
20140066361
2014-03-06

Peptides and use thereof in the inhibition of angiotensin converting enzyme

#3717
20140065175
2014-03-06

Carrier peptides for cell delivery

#3718
20140065152
2014-03-06

Antibody specifically recognizing an epitope for switching to T1 cell

#3719
20140057853
2014-02-27

Compositions of A-8R peptide

#3720
20140057852
2014-02-27

Treatment of cancers with A-8R peptide

#3721
20140057833
2014-02-27

Adiponectin receptor agonists and methods of use

#3722
20140057828
2014-02-27

Small peptide modulators of potassium channel trafficking

#3723
20140057291
2014-02-27

Bisubstrate fluorescent probes for protein kinase CK2

#3724
20140056871
2014-02-27

Anti-inflammatory antibodies and uses therefor

#3725
20140056855
2014-02-27

LLP2A-bisphosphonate conjugates for osteoporosis treatment

#3726
20140056847
2014-02-27

INHIBITORS OF SERINE PROTEASES

#3727
20140056820
2014-02-27

Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof

#3728
20140051647
2014-02-20

Synthetic peptide that induces expression of TNF receptor 2 and use thereof

#3729
20140050751
2014-02-20

Mesothelin vaccines and model systems

#3730
20140050749
2014-02-20

MHC-I restricted epitopes containing non-natural amino acid residues

#3731
20140050662
2014-02-20

Prostate specific antigen agents and methods of using same for prostate cancer imaging

#3732
20140045771
2014-02-13

NOVEL DIPEPTIDYL PEPTIDASE IV (DP-IV) COMPOUNDS

#3733
20140045769
2014-02-13

Hydrogen bond surrogate macrocycles as modulators of Ras

#3734
20140045768
2014-02-13

Tight junction protein modulators and uses thereof

#3735
20140045750
2014-02-13

Methods of protecting against apoptosis using lipopeptides

#3736
20140045747
2014-02-13

METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS

#3737
20140045743
2014-02-13

Compositions and methods for coronavirus inhibition

#3738
20140045247
2014-02-13

Fusion protein

#3739
20140044778
2014-02-13

Nanoparticles containing pH-responsive peptide

#3740
20140044754
2014-02-13

TDF-related compounds and analogs thereof

#3741
20140044725
2014-02-13

ALZHEIMER'S DISEASE TREATMENT METHOD

#3742
20140044686
2014-02-13

Molecular marker for cancer stem cell

#3743
20140044655
2014-02-13

Activator peptides for synthesizing extracellular matrix proteins, and cosmetic compositions including same

#3744
20140044649
2014-02-13

Beta sheet tapes ribbons in tissue engineering

#3745
20140039155
2014-02-06

AMYLOID-BETA PEPTIDE CRYSTAL STRUCTURE

#3746
20140038909
2014-02-06

Tissue occluding agent comprising an IEIKIEIKIEIKI peptide

#3747
20140038898
2014-02-06

Peptides for suppressing inflammation

#3748
20140038880
2014-02-06

Compositions and methods for promoting wound healing and tissue regeneration

#3749
20140037755
2014-02-06

MAPKAP kinase-2 as a specific target for blocking proliferation of P53-defective

#3750
20140037626
2014-02-06

Metal Abstraction Peptide With Release of Metal

#3751
20140037623
2014-02-06

Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1

#3752
20140037560
2014-02-06

Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same

#3753
20140037547
2014-02-06

Peptidic activators of type I cGMP dependent protein kinases and uses thereof

#3754
20140031523
2014-01-30

Selective Poly-N-Substituted Glycine Antibiotics

#3755
20140031293
2014-01-30

Therapeutic agents with improved fibrinogen binding

#3756
20140030242
2014-01-30

Antifungal composition comprising polycyclic peptide compound and method for preparing the same

#3757
20140024810
2014-01-23

Modified antibody compositions, methods of making and using thereof

#3758
20140024606
2014-01-23

Peptidomimetics comprising N-amino cyclic urea residues and uses thereof

#3759
20140024596
2014-01-23

DISEASE INHIBITING AGENT

#3760
20140023700
2014-01-23

Cyclic peptide and conjugate thereof for binding to keratinocytes

#3761
20140023671
2014-01-23

TOMM34 peptides and vaccines including the same

#3762
20140023670
2014-01-23

Cancer vaccine composition

#3763
20140018300
2014-01-16

Neuroprotective and neurorestorative methods and compositions

#3764
20140011979
2014-01-09

Stitched polypeptides

#3765
20140011734
2014-01-09

Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion

#3766
20140011730
2014-01-09

Melanocortin receptor ligands modified with hydantoin

#3767
20140005359
2014-01-02

Branched chain-containing aromatic compound

#3768
20140005117
2014-01-02

COMPOSITIONS AND METHODS FOR TREATING AIDS OR CANCER BY INHIBITING THE SECRETION OF MICROPARTICLES

#3769
20140005114
2014-01-02

β-arrestin effectors and compositions and methods of use thereof

#3770
20140005097
2014-01-02

Bioactive peptides and methods of using same

#3771
20140004137
2014-01-02

IMMUNE RESTRICTED PEPTIDES WITH INCREASED EFFICACY

#3772
20140004130
2014-01-02

MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo

#3773
20140004114
2014-01-02

Stable and soluble antibodies inhibiting VEGF

#3774
20130345394
2013-12-26

NPR-B agonists

#3775
20130345393
2013-12-26

Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method

#3776
20130345155
2013-12-26

Modulators for SIRT6 and assays for screening same

#3777
20130345136
2013-12-26

Methods of treating ophthalmic diseases using NPR-B agonists

#3778
20130345117
2013-12-26

Peptide-phospholipid conjugates

#3779
20130344592
2013-12-26

Factor H binding peptides and uses thereof

#3780
20130343989
2013-12-26

Methods and compositions related to internalizing RGD peptides

#3781
20130338085
2013-12-19

Mucin hypersecretion inhibitors and methods of use

#3782
20130338076
2013-12-19

Peptides and methods using same for diagnosis and treatment of amyloid-associated disease

#3783
20130338075
2013-12-19

Methods and compositions for the treatment of axonal and neuronal degeneration

#3784
20130338061
2013-12-19

Salts and Polymorphs of Sulfamide NS3 Inhibitors

#3785
20130337085
2013-12-19

Use of ide as a biomarker for a scalp condition

#3786
20130337050
2013-12-19

Drug transporter permeating blood-brain barrier, peptide and use thereof

#3787
20130337028
2013-12-19

BIOMIMETIC PEPTIDES FOR BONE AUGMENTATION

#3788
20130336904
2013-12-19

Anti-ageing peptides modulating survivin and compositions including same

#3789
20130331333
2013-12-12

PAR1 and PAR2 c-tail peptides and peptide mimetics

#3790
20130330744
2013-12-12

Nitrated cardiac troponin I as a biomarker of cardiac ischemia

#3791
20130330422
2013-12-12

METHODS FOR INCREASING INSULIN SENSITIVITY AND TREATING DIABETES WITH A BIOACTIVE CHROMIUM BINDING PEPTIDE

#3792
20130330368
2013-12-12

Eye drop composition for prevention and treatment of ophthalmic diseases containing fusion protein of FK506 binding protein

#3793
20130326728
2013-12-05

AGENTS FOR INCREASED RESISTANCE AGAINST OXIDATIVE STRESS CONDITIONS

#3794
20130323285
2013-12-05

Peptide adjuvants

#3795
20130323187
2013-12-05

SYNTHETIC PEPTIDES FOR USE AS INHIBITORS OF NEUROTRANSMITTER SECRETION AND AS INDUCERS OF CELLULAR RELAXATION

#3796
20130316964
2013-11-28

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#3797
20130316956
2013-11-28

NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF

#3798
20130316951
2013-11-28

Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same

#3799
20130316942
2013-11-28

Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof

#3800
20130315916
2013-11-28

Respiratory syncytial virus vaccine

#3801
20130315856
2013-11-28

Conjugates for the treatment of mesothelioma

#3802
20130310313
2013-11-21

Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides

#3803
20130310303
2013-11-21

Glycogen synthase kinase-3 inhibitors

#3804
20130309259
2013-11-21

WDHD1 peptides and vaccines including the same

#3805
20130309193
2013-11-21

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

#3806
20130303728
2013-11-14

Ligand and metal complex having the same

#3807
20130303457
2013-11-14

Cell-protective peptides and uses thereof

#3808
20130303441
2013-11-14

Glycogen synthase kinase-3 inhibitors

#3809
20130303439
2013-11-14

CHIMERIC PEPTIDES INCLUDING A PENETRATING PEPTIDE AND A BINDING DOMAIN OF PP2A CATALYTIC SUBUNIT TO CASPASE-9

#3810
20130303435
2013-11-14

Smart pro-drugs of serine protease inhibitors

#3811
20130302249
2013-11-14

Intestinal peptide targeting ligands

#3812
20130296530
2013-11-07

Use of peptides for promoting wound healing

#3813
20130296252
2013-11-07

MUC18 TARGETING PEPTIDES

#3814
20130296250
2013-11-07

METHOD FOR TREATMENT OF PSORIASIS

#3815
20130296226
2013-11-07

METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS

#3816
20130296224
2013-11-07

METHOD FOR TREATMENT OF INFLAMMATORY DISEASE AND DISORDER

#3817
20130295123
2013-11-07

Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy

#3818
20130289238
2013-10-31

PAR4 agonist peptides

#3819
20130288978
2013-10-31

Dermatopontin-activating peptides and cosmetic compositions including same

#3820
20130288965
2013-10-31

Use of peptides for promoting wound healing

#3821
20130288963
2013-10-31

Anticancer fusion protein comprising trail and a growth factor receptor inhibitor

#3822
20130288961
2013-10-31

Methods for treating steatotic disease

#3823
20130288363
2013-10-31

SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same

#3824
20130287807
2013-10-31

COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE

#3825
20130281662
2013-10-24

Process for the manufacture of Degarelix and its intermediates

#3826
20130281661
2013-10-24

Process for the manufacture of Degarelix and its intermediates

#3827
20130281660
2013-10-24

Detection of degradative enzymes and biomolecules in bodily fluids

#3828
20130281384
2013-10-24

Larazotide acetate compositions

#3829
20130281360
2013-10-24

Broad spectrum antibiotic arylomycin analogs

#3830
20130280281
2013-10-24

SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF

#3831
20130274208
2013-10-17

Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease

#3832
20130274206
2013-10-17

Compositions and methods for promoting wound healing and tissue regeneration

#3833
20130274202
2013-10-17

Peptides for treating cancer

#3834
20130274201
2013-10-17

Selective anticancer chimeric peptides which bind neuropilin receptor

#3835
20130274200
2013-10-17

Selective anticancer chimeric peptides which bind transferrin receptor

#3836
20130274178
2013-10-17

Active cores of peptide triazole HIV-1 entry inhibitors

#3837
20130274177
2013-10-17

Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof

#3838
20130274176
2013-10-17

β-arrestin effectors and compositions and methods of use thereof

#3839
20130273090
2013-10-17

Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use

#3840
20130267470
2013-10-10

Treatment of penetrative injury to the brain

#3841
20130266604
2013-10-10

PEPTIDE CONTAINING MULTIPLE N-LINKED GLYCOSYLATION SEQUONS

#3842
20130266597
2013-10-10

Small cationic antimicrobial peptides

#3843
20130266537
2013-10-10

Moesin modulators and uses thereof

#3844
20130261066
2013-10-03

TREATMENT OF INFLAMMATORY BOWEL DISEASES USING A TRIPEPTIDE

#3845
20130259884
2013-10-03

PEPTIDES

#3846
20130259883
2013-10-03

CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS

#3847
20130252906
2013-09-26

Compounds and methods for treating or preventing disease conditions associated with α-1-antitrypsin

#3848
20130252895
2013-09-26

Peptides of syndecan-1 for inhibit angiogenesis

#3849
20130251719
2013-09-26

BONE MARROW APLASIA WITH HAEMORRHAGIC DISEASE IN CALVES CAUSED BY NOVEL PATHOGEN

#3850
20130251628
2013-09-26

Ligands to radiation-induced molecules

#3851
20130245100
2013-09-19

Polynucleotide for use in treatment of influenza A virus induced diseases, encoding modified Mx protein, said modified Mx protein, and a transgenic animal expressing gene encoding modified Mx protein

#3852
20130244947
2013-09-19

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

#3853
20130244946
2013-09-19

Compositions for treatment of neurodegenerative diseases

#3854
20130244934
2013-09-19

VIP fragments and methods of use

#3855
20130244928
2013-09-19

Antimicrobial peptides and derived metapeptides

#3856
20130244925
2013-09-19

Molecules mimicking an autoantibody idiotype and compositions containing same

#3857
20130244232
2013-09-19

HIGH-EFFICIENCY CATALYSTS, PREPARATION AND USE THEREOF

#3858
20130243802
2013-09-19

Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy

#3859
20130243711
2013-09-19

TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same

#3860
20130237688
2013-09-12

MULTIMODALITY AGENTS FOR TUMOR IMAGING AND THERAPY

#3861
20130237484
2013-09-12

Cell-permeable peptide

#3862
20130237473
2013-09-12

Melanocortin receptor-specific peptides

#3863
20130236888
2013-09-12

Enzyme substrate comprising a functional dye and associated technology and methods

#3864
20130231289
2013-09-05

Synthetic analogues of neural regeneration peptides

#3865
20130231251
2013-09-05

Methods for selective targeting

#3866
20130230591
2013-09-05

Peptide for use as a medicament, in particular for the treatment of cancer

#3867
20130230544
2013-09-05

Immunostimulatory method

#3868
20130225508
2013-08-29

PEPTIDE CAPABLE OF BINDING TO IMMUNOGLOBULIN

#3869
20130225488
2013-08-29

Antidiabetic compounds

#3870
20130225481
2013-08-29

Antimicrobial peptides

#3871
20130224880
2013-08-29

REAGENTS AND METHODS FOR DETECTING PROTEIN CROTONYLATION

#3872
20130224760
2013-08-29

Zinc-responsive peptides, and methods of use thereof

#3873
20130224285
2013-08-29

ESTROGEN RECEPTOR ALPHA POLYPEPTIDE SEQUENCE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF

#3874
20130224231
2013-08-29

Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity

#3875
20130224182
2013-08-29

BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE

#3876
20130217858
2013-08-22

Compositions and methods for modulating γ-c-cytokine activity

#3877
20130217857
2013-08-22

ErbB interface peptidomimetics and methods of use thereof

#3878
20130217619
2013-08-22

Linear peptide antibiotics

#3879
20130217047
2013-08-22

Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof

#3880
20130216583
2013-08-22

VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A PEPTIDE HAVING ADJUVANT PROPERTIES

#3881
20130216567
2013-08-22

Avian group D rotavirus

#3882
20130216494
2013-08-22

Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof

#3883
20130211049
2013-08-15

Immunotoxin fusion proteins and means for expression thereof

#3884
20130210751
2013-08-15

Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands

#3885
20130210749
2013-08-15

PEPTIDES, CONSTRUCTS AND USES THEREFOR

#3886
20130210748
2013-08-15

METHOD AND PEPTIDE FOR REGULATING CELLULAR ACTIVITY

#3887
20130210741
2013-08-15

Immunoregulatory peptides and methods of use

#3888
20130210711
2013-08-15

Production and use of antitumoral antibiotic and insecticidal cyclodepsipeptides

#3889
20130210709
2013-08-15

CXCR4 receptor compounds

#3890
20130209551
2013-08-15

PENTAPEPTIDE DERIVATIVES FOR PROMOTING HAIR GROWTH

#3891
20130209541
2013-08-15

IL-13 receptor binding peptides

#3892
20130205416
2013-08-08

ANTI-VIRAL AGENT

#3893
20130203686
2013-08-08

Azapeptides as CD36 binding compounds

#3894
20130203685
2013-08-08

PROTEASE TARGETING AGENTS

#3895
20130203683
2013-08-08

Immunoregulatory peptides and methods of use

#3896
20130203679
2013-08-08

Immunoregulatory peptides and methods of use

#3897
20130203677
2013-08-08

Bioactive peptide

#3898
20130203662
2013-08-08

Mini-Hepcidin Peptides and Methods of Using Thereof

#3899
20130203654
2013-08-08

Cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same

#3900
20130203649
2013-08-08

Inhibitors of TLR signaling by targeting TIR domain interfaces